CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT00086840 · TERMINATED

Trial details

NCT number: NCT00086840
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia

Start date: 2004-05-01
Primary completion: 2005-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.